Marieme Dembele

Marieme Dembele

Auto-generated profile, based on publicly available information

Marieme Dembele

The McGill University Health Center

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DXDi Xue
Di Xue
GKGabriel N. Kaufman
Gabriel N. Kaufman
MDMarieme Dembele
Marieme Dembele
MBMarianne Beland
Marianne Beland
AMAmir H. Massoud
Amir H. Massoud
BMBruce D. Mazer
Bruce D. Mazer
The regulatory properties of B cells have been studied in autoimmune diseases; however, their role in allergic diseases is poorly understood. We demonstrate that Semaphorin 4C (Sema4C), an axonal guidance molecule, plays a crucial role in B cell regulatory function. Mice deficient in Sema4C exhibited increased airway inflammation after allergen exposure, with massive eosinophilic lung infiltrates and increased Th2 cytokines. This phenotype was reproduced by mixed bone marrow chimeric mice with Sema4C deficient only in B cells, indicating that B lymphocytes were the key cells affected by the absence of Sema4C expression in allergic inflammation. We determined that Sema4C-deficient CD19+CD138+ cells exhibited decreased IL-10 and increased IL-4 expression in vivo and in vitro. Adoptive transfer of Sema4c−/− CD19+CD138+ cells induced marked pulmonary inflammation, eosinophilia, and increased bronchoalveolar lavage fluid IL-4 and IL-5, whereas adoptive transfer of wild-type CD19+CD138+IL-10+ cells dramatically decreased allergic airway inflammation in wild-type and Sema4c−/− mice. This study identifies a novel pathway by which Th2-mediated immune responses are regulated. It highlights the importance of plasma cells as regulatory cells in allergic inflammation and suggests that CD138+ B cells contribute to cytokine balance and are important for maintenance of immune homeostasis in allergic airways disease. Furthermore, we demonstrate that Sema4C is critical for optimal regulatory cytokine production in CD138+ B cells.

1 April 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AMAmir H. Massoud
Amir H. Massoud
GKGabriel N. Kaufman
Gabriel N. Kaufman
DXDi Xue
Di Xue
MBMarianne Béland
Marianne Béland
MDMarieme Dembele
Marieme Dembele
BMBruce D. Mazer
Bruce D. Mazer
IVIg is widely used as an immunomodulatory therapy. We have recently demonstrated that IVIg protects against airway hyperresponsiveness (AHR) and inflammation in mouse models of allergic airways disease (AAD), associated with induction of Foxp3+ regulatory T cells (Treg). Using mice carrying a DTR/EGFP transgene under the control of the Foxp3 promoter (DEREG mice), we demonstrate in this study that IVIg generates a de novo population of peripheral Treg (pTreg) in the absence of endogenous Treg. IVIg-generated pTreg were sufficient for inhibition of OVA-induced AHR in an Ag-driven murine model of AAD. In the absence of endogenous Treg, IVIg failed to confer protection against AHR and airway inflammation. Adoptive transfer of purified IVIg-generated pTreg prior to Ag challenge effectively prevented airway inflammation and AHR in an Ag-specific manner. Microarray gene expression profiling of IVIg-generated pTreg revealed upregulation of genes associated with cell cycle, chromatin, cytoskeleton/motility, immunity, and apoptosis. These data demonstrate the importance of Treg in regulating AAD and show that IVIg-generated pTreg are necessary and sufficient for inhibition of allergen-induced AAD. The ability of IVIg to generate pure populations of highly Ag-specific pTreg represents a new avenue to study pTreg, the cross-talk between humoral and cellular immunity, and regulation of the inflammatory response to Ags.

4 November 2017 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
MDMarylin Desjardins
Marylin Desjardins
MBMarianne Béland
Marianne Béland
MDMarieme Dembele
Marieme Dembele
DLDuncan Lejtenyi
Duncan Lejtenyi
JDJean-Phillipe Drolet
Jean-Phillipe Drolet
BMBruce D. Mazer
Bruce D. Mazer

1 February 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
MDMarieme Dembele
Marieme Dembele
STShao Tao
Shao Tao
AMAmir Massoud
Amir Massoud
VZVictoria Zismanov
Victoria Zismanov
GKGabriel Kaufman
Gabriel Kaufman
Anne Searls De GrootAnne Searls De Groot
Anne Searls De Groot

5 April 2016 in Neurology
Verified
Journal Article
Closed access
DKDorlan Kimbrough
Dorlan Kimbrough
KFKathryn Fitzgerald
Kathryn Fitzgerald
OAOmar Al-Louzi
Omar Al-Louzi
JBJulia Button
Julia Button
MDMarieme Dembele
Marieme Dembele
PCPeter A Calabresi
Peter A Calabresi

23 March 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMitja Mitrovic
Mitja Mitrovic
NPNikolaos Patsopoulos
Nikolaos Patsopoulos
ABAshley Beecham
Ashley Beecham
TDTheresa Dankowski
Theresa Dankowski
AGAn Goris
An Goris
TAThe Australia
The Australia
Multiple sclerosis is a common, complex neurological disease, where almost 20% of risk heritability can be attributed to common genetic variants, including >230 identified by genome-wide association studies (Patsopoulos et al., 2017). Multiple strands of evidence suggest that the majority of the remaining heritability is also due to the additive effects of individual variants, rather than epistatic interactions between these variants, or mutations exclusive to individual families. Here, we show in 68,379 cases and controls that as much as 5% of this heritability is explained by low-frequency variation in gene coding sequence. We identify four novel genes driving MS risk independently of common variant signals, which highlight a key role for regulatory T cell homeostasis and regulation, IFNγ biology and NFκB signaling in MS pathogenesis. As low-frequency variants do not show substantial linkage disequilibrium with other variants, and as coding variants are more interpretable and experimentally tractable than non-coding variation, our discoveries constitute a rich resource for dissecting the pathobiology of MS.